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W e report on transapical implantation of an uncovered aortic endostent for treatment of iatrogenic acute type A aortic dissection.
A 91-year-old female patient presented with recent onset of increasing shortness of breath and fatigue and temporary disorientation caused by severe aortic valve stenosis ( Figure  1 and online-only Data Supplement Videos 1 and 2). Her medical history included cachexia (body mass index, 17.9 kg/m 2 ; body surface area, 1.39 m 2 ), severe spondylosis, osteochondrosis, and osteoporotic vertebral body fracture. Transcatheter aortic valve implantation (TAVI) was favored because of her frailty, poor general condition and increased risk for conventional surgery (logistic EuroSCORE, 29%; STS score, 13%). The transapical approach for TAVI was chosen because of tortuosity and atherosclerotic disease of the small iliaco-femoral arteries. The procedure was monitored by fluoroscopy, angiography, and continuous transesophageal echocardiography (TEE). After implantation of a 23-mm Edwards-Sapien valve (Edwards-Sapien THV, Edwards Lifesciences, Irvine, CA), TEE and angiography showed a new finding of dissection of the whole aorta and also excluded possible intimal tear ("entry") in the proximal or mid ascending aorta ( Figures 2 and 3 and onlineonly Data Supplement Videos 3-6). We closed the false lumen in the ascending aorta and aortic arch by immediate transapical implantation of an uncovered aortic endostent into the ascending aorta and aortic arch. We chose the uncovered aortic self-expandable aortic E-xl endostent (Jotec, Hechingen, Germany), 130 mm in length and with a 40-mm diameter of the proximal and distal ends (2 mm larger than the lumen of the ascending aorta). The selfexpandable stent was introduced over the stiff guide wire antegrade through the apex of the heart (Figure 4 It can be expected that this iatrogenic complication can occur during all sequences of all types of TAVI procedure. The predisposing factors for iatrogenic dissection might be the presence of severely atheromatous or partially calcified aortic wall with ulcerated plaques and dilatation of the aorta with a tender and fragile wall. We believe that this particular complication was a consequence of additional manipulation with a stiff guide wire and adjustment of its position during TAVI. Possibly this complication could have been avoided by very gentle placement and very careful manipulation with the stiff guide wire, omitting unnecessary manipulation during the procedure. Standard treatment for iatrogenic acute type A aortic dissection during the TAVI procedure is the same as for dissection of natural origin. It consists of immediate conventional surgical therapy because of imminent danger of possible aortic rupture and pericardial tamponade and/or obstruc-tion of the coronary artery ostia. However, the risk of conventional surgery was assessed to be very high in this 91-year-old patient. This is the first report of type A aortic dissection being treated with an uncovered aortic endostent by direct transapical implantation into the ascending aorta. The transapical approach enabled precise deployment of the aortic endostent because of the short distance from the apex of the heart to the aortic valve and the ascending aorta. It achieved immediate closure of the false lumen and eliminated possible complications.
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